Difference between revisions of "Team:NCTU Formosa"

Line 206: Line 206:
 
      <div class="photocontent1"><h2>Who are we</h2>
 
      <div class="photocontent1"><h2>Who are we</h2>
 
       NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO     
 
       NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO     
−
         devoted to developing detection technology by uti-  lizing antibodies. In 2015, We cooperated with iGEM with Synthetic 
+
         devoted to developing detection technology by utilizing antibodies. In 2015, we cooperated with iGEM to develop a brand  
−
        Biology to develop a brand new detection platform.</div>
+
        new detection platform by using synthetic biology.</div>
 
    </div>
 
    </div>
 
              
 
              

Revision as of 18:06, 18 September 2015

The only thing we can detect is everything.

Who are we

NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO devoted to developing detection technology by utilizing antibodies. In 2015, we cooperated with iGEM to develop a brand new detection platform by using synthetic biology.

What's new

APOllO E.Cotector:
Our organization create a customized scFv detection platform by co-transforming any desired plasmid. ScFv utilizing antigen -antibody interaction can act as probes. Our E.Cotector can therefore have the function of a detector.

What do we care

In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more patients can afford it. Therefore, more patients can be prescribed and treated, lowering the mortality rate of cancer.